Antibody Modification and Conjugation Technologies
Other Conjugation Approaches
Unnatural Amino Acids Conjugation
ADC Payloads Development
ADC Analysis and Characterization
ADC Linkers Development
ADC Linker and Cytotoxin Conjugations
ADCs Cytotoxin with Linkers
Cytotoxic payloads in ADCs
Disitamab Vedotin for the treatment of urothelial cancer was approved by the US FDA
Exatecan mesylate: a novel topoisomerase I inhibitor in ADC technolog
New medicine for lymphoma! Antibody-Drug Conjugate (ADC) loncastuximab tesirine (Lonca) applies for listing!
TF-targeted antibody-drug conjugate (ADC) tisotumab vedotin shows strong efficacy and will be applied marketing
The development history of ADC drugs
What is antibody drug conjugates?
What is Calicheamicin？
What is Monomethyl Auristatin E (MMAE)?
What is Monomethyl Auristatin F (MMAF)?
What is Pyrrolobenzodiazepine (PBD)?
Only for research. Not suitable for any diagnostic or therapeutic use.
Go to checkout